CKD: Consolidated financial results for the first quarter ending March 2025 (based on Japanese standards)
CKD: Interim report
CKD: Financial Report - 104th Term (2023/04/01 - 2024/03/31)
CKD: Confirmation letter
CKD: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
CKD: Notice regarding dividends from surplus funds
CKD: Quarterly Report - 104th Quarter (2023/10/01 - 2023/12/31)
CKD: Confirmation
CKD: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)
CKD: Quarterly Report - 104th Second Quarter (2023/07/01 - 2023/09/30)
CKD: Confirmation letter
CKD: Notice Concerning Revisions to Full-Year Consolidated Earnings Forecasts, Dividends from Surplus Funds (Interim Dividends), and Revisions to Year-End Dividend Forecasts
CKD: Summary of Financial Results for the 2nd Quarter Ending March 2024 [Japanese GAAP] (Consolidated)
CKD: Quarterly Report - 104th Quarter 1st Quarter (2023/04/01 - 2023/06/30)
CKD: Confirmation letter
CKD: Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
CKD: Extraordinary Report
CKD: Securities Report - 103rd Period (2022/04/01 - 2023/03/31)
CKD: Confirmation letter
CKD: Confirmation letter
No Data